OXYTROL 3.9 mg/day (oxybutynin transdermal system). Each 39 cm2 system imprinted with OXYTROL 3.9 mg/day contains 36 mg oxybutynin for nominal delivery of 3.9 mg oxybutynin per day when dosed in a twice weekly regimen.
NDC 52544-920-08 Patient Calendar Box of 8 Systems
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Protect from moisture and humidity. Do not store outside the sealed pouch. Apply immediately after removal from the protective pouch. Discard used OXYTROL in household trash in a manner that prevents accidental application or ingestion by children, pets, or others.
A subsidiary of Watson Pharmaceuticals, Inc.
Corona, CA 92880 USA
U.S. Patent Nos. 5,601,839 and 5,834,010